Loss of selective muscle activation after stroke contributes to impaired arm function, is difficult to quantify and is not systematically assessed yet. The aim of this study was to describe and validate a technique for quantification of selective muscle activation of wrist flexor and extensor muscles in a cohort of post-stroke patients. Patterns of selective muscle activation were compared to healthy volunteers and test-retest reliability was assessed.
INTRODUCTION
In post-stroke patients, impaired arm and hand function is determined by a complex interaction of primary neurological deficits and secondary changes in connective and contractile tissue [1] [2] [3] . Amidst these changes, loss of selective muscle activation plays a role [4] [5] [6] [7] . The ability to voluntarily contract a muscle and to have selective control of antagonistic muscles predominantly defines the torque output a patient can generate during a task.
Loss of selective muscle activation may result in energetically inefficient co-contraction and impaired dexterity in the affected limb [8] [9] [10] [11] . Moreover, loss of selective muscle activation [12] may result in a lower torque output at joint level than expected by the level of paresis alone [13] . We expect clinical phenotypes to diverge from 1) patients with flaccid paresis, i.e. no selective muscle activation, to 2) patients with some loss of selective muscle activation, and 3) patients with normal selective muscle activation combined with either low or normal torque output. Addressing the role of selective muscle activation to loss of function is important in clinical decision making, e.g. to optimize patient selection and timing of costly or labor intensive therapies such as mCIMT or botulinum toxin.
Selective muscle activation is not yet assessed routinely in post-stroke patients.
Current measures may have methodological drawbacks. For example, comparison of electromyography (EMG) signals of agonistic and antagonistic muscles is a frequently applied technique [14] [15] [16] [17] [18] . Yet the comparison of agonist and antagonist EMG-signals is for instance troubled by differences in volume of the muscles in an agonist-antagonist muscle pair [19, 20] and complicated in case of spasticity [9] , which makes quantification of selective muscle activation with this technique challenging. Furthermore, quantification of selective muscle activation by comparison of EMG-signals of the same muscle in the ipsilateral and contralateral sides [13, 21] may be hampered, as muscle properties of the unaffected side should not be regarded as normal in post-stroke patients [22] [23] [24] [25] [26] . Moreover, proper address of selective muscle activation is of importance as morphological changes interfering with contractile behavior are already reported in the early phase after stroke [27] .
In this study we describe selective muscle activation by comparing EMG-signals of wrist muscles during two isometric but antagonistic task conditions, using the normalized ratio of the EMG-signals per muscle group, also called Activation Ratio (AR) [28] . This method is methodologically advantageous because it describes the activation of both flexor and extensor muscles in relation to their expected agonistic and antagonistic function. AR may be applied to antagonist muscle pairs provided the axis of movement is controlled (limitation in degrees of freedom). Selective muscle activation around the wrist joint had our special interest because of its role in lasting impairment in arm-hand function after stroke, e.g. in case of flexion deformity. Muscle specific AR is assumed to assist in a better definition of clinical phenotypes in post-stroke patients. However, this method has not been evaluated in post-stroke patients yet. Our aim was to describe and validate this technique for quantification of selective muscle activation of wrist flexor and extensor muscles in a cohort of post-stroke patients. Patterns of selective muscle activation were compared to healthy volunteers and test-retest reliability was assessed.
METHODS

Participants
The study cohort consisted of 31 stroke survivors and 14 healthy volunteers. Post-stroke patients were recruited from an outpatient rehabilitation department. Inclusion criteria were: first ischemic stroke between 1999 -2009, age 18 -80 years, a perceived persistent impairment of arm-hand function by the participant, being able to travel to the research laboratory, and being able to sit on a chair and follow instructions for one hour. Exclusion criteria were: previous orthopedic limitations of arm-hand function, a history of other neurologic impairments besides stroke. Participants were measured between November 2008 and January 2010 on two occasions within a month, under the assumption that clinical status would remain stable. Stroke onset was more than 6 months prior to assessment.
Ethical approval for the study was received from the medical ethical committee at the Leiden University Medical Center and written informed consent was obtained from each participant prior to testing.
Protocol
Participants were instructed to perform a voluntary isometric maximal flexion or extension torque, starting from a relaxed condition. The voluntary maximal isometric torque (MIT) had to be attained within a 15 second timeframe, followed by a minimum of 60 seconds rest. This procedure was performed twice for both flexion and extension. The position of the wrist during the test was a neutral angle where the average measured torque during a slow passive movement through the range of motion was 0 Nm (Rest Angle) [29] . For motivational purposes, visual feedback was provided on a computer screen. This feedback consisted of a vertical bar which showed both instantaneous and maximal attained torque.
Measurement set-up
Tests were performed on a haptic wrist manipulator (Wristalyzer®, Moog FCS, Nieuw Vennep, the Netherlands) [30] , on which torque and wrist joint angle were recorded. Participants were comfortably seated on a chair in front of a video screen. The forearm of the participant was positioned horizontally with the elbow in 90° flexion. The hand was strapped to an ellipsoidal shaped handle ( Figure 1 ) to prevent finger flexion and hand closure. The skin at the electrode positions was cleansed with alcohol and lightly abraded with skin preparation gel (SkinPure, Nihon Kohden, Japan). EMG activity of the m. flexor carpi radialis (FCR) and m. extensor carpi radialis longus and brevis (together abbreviated as ECR) was recorded by bipolar parallel bar surface electrodes (Bagnoli® DE-2.1, Ag, single differential, inter electrode distance 10 mm; Bagnoli-8 amplifier, Delsys Inc., Boston, USA). FCR and ECR were chosen to reflect overall muscle activity of wrist flexor and extensors. Both muscles are the less pennate muscles of the lower arm, have good accessibility with surface EMG and are therefore likely to suffer less from measurement artefacts. Two bipolar electrodes were placed on each muscle group to ensure that a signal was available and to compensate for spatial alterations in the affected (atrophic) muscle after stroke [31] . Position, force and EMG were sampled at 2048Hz using a 16 bit analog-to-digital card (USB 6221, National Instruments, Austin, USA) [29] . For a better view of the hand position, the hand straps are not shown.
Data processing
Data were processed with Matlab® (Mathworks, Natick, USA). Selective activation of FCR and ECR were computed by means of Activation Ratio (AR). This is an EMG-based method [28] , which requires voluntary muscle activation. In patients with flaccid paresis, voluntary muscle activation is insufficient to distinguish between resting state and active conditions, and therefore insufficient to determine selective muscle activation. In this study, insufficient voluntary muscle activation was defined as EMG activity during the isometric maximal torque task of less than three times standard deviation above baseline EMG. When insufficient EMG activity was established for a trial, the trial was excluded from analysis.
AR was calculated per bipolar electrode according to equation 1 [28] , where AIP is the inphase muscle activation, i.e. activity during the agonistic task; and AOP is the out-of-phase muscle activation, i.e. activity during the antagonistic task of the muscle. An AR close to one indicates optimal in-phase (selective) muscle activation. If the AR equals zero, muscle activation is equal during flexion and extension. A negative AR indicates out-of-phase muscle activation, i.e. the muscle is more active during its antagonistic task than during its agonistic task.
Raw EMG signals (online band pass filter 20-450 Hz) were rectified and smoothened by a 2Hz 3 rd order Butterworth low pass filter [32] . Torque data were also smoothened with a 3 rd order Butterworth low pass filter of 2 Hz. Smoothened torque data and corresponding EMG signals were sorted along torque magnitude with intervals of 0.01 Nm. Then AR were computed for each torque level using both flexor and extensor task data within the available torque range (containing matching torques from both flexion and extension task)
per bipolar electrode. The average AR was then computed per bipolar electrode, resulting in two AR for FCR and two AR for ECR per trial.
Statistical methods
SPSS 20 (IBM, New York, USA) was used for statistical analysis. For each participant, the average AR flex for FCR and average AR ext for ECR per visit was computed from the mean AR per bipolar electrode per trial (EMG was recorded by two bipolar electrodes per muscle group and participants had two trials per visit), after checking for systematic differences between the electrodes and trials using Wilcoxon rank sum test and scatter plots.
Test-retest reliability of AR was established by Intraclass correlation coefficient (ICC) between the two visits. ICC were calculated using the two-way mixed model for absolute agreement.
Values above 0.75 were assumed to represent excellent reliability, values between 0.4 and 0.75 to represent fair to good reliability and values below 0.4 to represent poor reliability [33] . As ICC is a relative measure dependent on variance between measurements compared to total variance [34] , Bland Altman plots were used to illustrate variability. Standard Error of Measurement (SEM) values were calculated to further substantiate ICC according to equation 2.
Equation 2 SEM = SD*√(1-ICC)
At parameter level, normality of distribution was inspected with histograms and equality of variances between healthy volunteers and post-stroke patients was tested with Levene's test. Age was normally distributed, equal variances were assumed (Levene's test p = 0.78).
The independent samples t-test was used to compare age between healthy volunteers and post-stroke patients. AR were not normally distributed within groups and variance was not equal between groups (Levene's test for AR flex p = 0.018, and for AR ext p < 0.001), hence median and range were used and the non-parametric Independent Samples Median Test was used for comparison between post-stroke patients and healthy volunteers. The relation between AR flex and AR ext was tested with Spearman's rho correlation coefficient. Ratio of men to women within the two groups (post-stroke patients and healthy volunteers) was tested with the chi-square test.
RESULTS
Participants
All healthy volunteers completed all visits (100%) and 28 out of 31 patients completed all visits (90.3%). Reasons for dropping out were: unable to schedule the second visit (n = 2), patient was treated with botulinum toxin in period between first and scheduled second visit (n = 1). Demographics of the study population are summarized in table 1. Mean age in poststroke patients was 59 years (SD 13 year) and 50 years (SD 15 year) in healthy participants (p = 0.04 when tested for difference in age between group; 95% confidence interval for the difference: -18 years to -0.2 years). However, further analysis showed that age did not have a significant correlation with either ARflex (Pearson correlation -0.079 with p = 0.62) or
ARext (Pearson correlation -0.139 with p = 0.38), and in multivariate analysis, age was not a contributing factor. Therefore age was not corrected for in further analysis. The ratio of men to women was not statistically different in both categories (p = 0.14). Average time poststroke was 3 years (SD 2.5 year). More information on limb dominance in the post-stroke patient group can be found in Supplementary Figure S1 . modified Ashworth Score = 0 (n) n.a. 21
modified Ashworth Score ≥ 1 (n) n.a. 10
Voluntary muscle activation
Three out of 172 trials were excluded because of recording errors. Insufficient voluntary muscle activation was observed in both FCR and ECR in three post-stroke patients, indicating flaccid paresis. The trials of these three patients were excluded from analysis. In two additional post-stroke patients, there was insufficient voluntary muscle activation in the ECR only. Therefore, all trials regarding the extensor muscles of these two patients were excluded from analysis.
Quantification of selective muscle activation
A typical recording of a healthy participant is illustrated in Figure 2 An example of a post-stroke patient with loss of selective function of the ECR is shown in Figure 3 . Voluntary MIT were 7.8 Nm (flexion) and 5.4 Nm (extension). There was an increased EMG activity of the ECR during flexion. This EMG activity was almost equal to the EMG activity of the ECR during extension. Therefore the AR ext in this participant was close to zero (AR ext = 0.01). The FCR showed more selective activation (AR flex = 0.55).
Activation Ratios in post-stroke patients and healthy volunteers
Median AR flex was 0.62 and median AR ext was 0.71 overall in all participants. Median and range of AR in post-stroke patients and healthy participants, as well as voluntary MIT per group are summarized in table 2. Median AR flex and AR ext in post-stroke patients were significantly lower than in healthy participants (p = 0.022 and p = 0.003 respectively), this is graphically represented in Figure 4 . AR flex and AR ext were significantly correlated in post-stroke patients (Spearman's rho 0.486, p = 0.012), but not in healthy participants (Spearman's rho 0.262, p = 0.366), which can be inferred from Figure 5 . Test-retest reliability of AR flex and AR ext was excellent with ICC of 0.77 and 0.78 respectively. Bland Altman plots are shown in figure 6 , depicting the mean of the two measurements (x-axis) compared to the difference between two measurements (y-axis). The values are scattered around the mean difference (solid line), which is close to zero, illustrating the absence of a systematic difference or learning effect between the two measurements. The 95% confidence interval of the difference between the measurements (dotted lines) illustrates measurement error. SEM values provide an indication of the dispersion of the measurement errors. SEM were 0.11 for AR flex and 0.10 for AR ext . More information on the influence of variance on ICC and SEM can be found in Supplementary Figure S2 . 
Clinical Phenotypes
As introduced, clinical phenotypes were expected to diverge from 1) patients with flaccid paresis i.e. no selective muscle activation, to 2) patients with some loss of selective muscle activation combined with low torque output, and 3) patients with normal selective muscle activation combined with either low or normal torque output. To substantiate these phenotypes, combinations of AR and MIT can be used. In the first phenotype, voluntary muscle activation is insufficient to distinguish between resting state and active conditions, so AR cannot be quantified. In the second phenotype, combinations of low AR with both high and low MIT are found. In the third phenotype, a high AR in combination with either a high MIT or a low MIT is expected. Patients of phenotype 2 and 3 are graphically represented in Figure 7 Solid line: mean of the difference between first and second visits. Dotted line: upper and lower limit of 95% confidence interval for difference between first and second visit.
DISCUSSION
Although essential, establishing selective muscle activation does not reflect the full potential for treatment of a patient yet. Inappropriate muscle activation, i.e. exaggerated stretch reflexes, and secondary biomechanical properties, such as increased stiffness should also be taken into account [29, [35] [36] [37] [38] [39] . For example, loss of selective muscle activation might coincide with spasticity, for which botulinum toxin could be beneficial [40] [41] [42] , while loss of selective muscle activation combined with structural shortening of a muscle unresponsive to physical therapy might benefit more from surgery [43, 44] . In order to tailor treatment to patient characteristics, each clinical phenotype requires a different approach.
Strengths and limitations
The isotonic torque task preferred in earlier work [28] was modified to an isometric task during a maximal voluntary contraction. Voluntary maximal isometric torque is a widely used and easily applied clinimetric parameter that was already part of our test procedure.
The necessary sorting technique to align EMG-signals along torque magnitude (that is not necessary in isotonic tasks) proved to be feasible. The current short task in a single torque direction also had the advantage of avoiding fatigue and signal modifications due to steering. The present measurement set-up allowed for standardization, however, further analysis of the dependence on orientation of the upper limb is required when test results are to be translated to functional task performance (i.e. reaching, grabbing). Visual feedback might have supported any participants with diminished sensory functions, e.g. of the hand (visual feedback to compensate for lack of sensory feedback) or hemi-inattention or neglect (vertical bar), however, this was not tested. ICC might be different in a more homogenous population selected on stroke location or level of motor impairment. These data were not available in our population. Bearing in mind that morphological changes (i.e. shortening of structures) may occur as early as four weeks post-stroke [45] , the described neutral angle was chosen to minimize any influence of secondary biomechanical changes and to provide optimal conditions for the neural system in testing agonist and antagonist activity. Furthermore, an isometric task minimizes strain resulting from joint movement, allowing for isolated measurement of muscle activation.
Dotted line: lowest values of AR and MIT in healthy volunteers (see minimum for healthy volunteers in
AR were specifically developed in view of potential problems with normalization when comparing different muscles [28] . Issues with variance in quality, quantity and control of muscles as outlined in the introduction, are avoided by relating the activity of the same muscles in different tasks. Other drawbacks of EMG based methods that researchers should take into account [8, 46] are e.g. crosstalk and elevated background EMG activity.
Crosstalk might be increased by using two electrodes per muscle group, but only if the EMG-signal is relatively silent [47] . A small amount of crosstalk from other flexors besides FCR during flexion or other extensors besides ECR during extension would have negligible consequences for the results. Elevated background EMG activity, i.e. muscle EMG-activity at rest in post-stroke patients [48] could theoretically lead to unjustified exclusion of patients with insufficient voluntary muscle activation and falsely low AR by mechanism of a lower ratio of activity (in-phase) to rest (out-phase) EMG. However, as elevated background EMG in post-stroke patients was quantified at around 3% of maximal EMG during a maximal voluntary contraction task [48] , we assume that this had no influence on our definition of insufficient voluntary muscle activation and was of no clinical relevance for AR.
Future work
Objective and reproducible data such as AR support a more substantiated analysis of clinical phenotypes. In this light the next step is to gather longitudinal information on selective muscle activation to follow functional recovery of stroke patients over time [49] and to monitor results of treatment. Combining AR data and kinematic data could give a valuable insight into the connection between loss of selective muscle activation around a single joint (e.g. co-contraction or co-activation) and multi joint synergistic movements. Moreover, to help prevent under-or overtreatment and to ensure that not only the affected muscle but also the aims of the patient on activity and participation level are treated, knowledge on the relation between selective muscle activation and functional outcome is essential in the future design of treatment paradigms for post-stroke patients.
CONCLUSION
Activation Ratios allow for reliable muscle specific quantification of selective muscle activation in participants with sufficient voluntary muscle activity. We observed significantly lower Activation Ratios in the group of post-stroke patients compared to the group of healthy participants, which indicate loss of selective muscle activation in post-stroke patients. Information on loss of selective muscle activation will allow clinicians to improve clinical decision making, follow patients over time and monitor results of treatment.
